Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

$ (776) $ (150) ------------- -------------- e. Selling, general and administrative adjustments: --------------------------------------------------------------------- Three months Three months ended ended Dec 31, 2008 Dec 31, 2007 ------------- ------------- Stock-based compensation $ (333) $ (721) Termination and reorganization costs (1,245) (3,526) Litigation expenses relating to defending intellectual property claims (177) 971 Non-recurring financing fees (665) - --------------------------------------------------------------------- $ (2,420) $ (3,276) ------------- ------------- f. Amortization of acquisition related intangible assets and medical technologies. g. Non-recurring in-process research and development expense relating to payments made to licensors and collaborators. h. Foreign exchange fluctuations on foreign currency net monetary assets. i. Realized loss on disposition of assets and other capitalized costs. j. Amortization of deferred financing costs. k. Write-down of other deferred financing charges. l. Realized loss on disposition of investment and unrealized loss on write-down of investments. m. Loss on write-down of assets classified as held for sale. n. Loss on write-down of goodwill. o. Tax effects of adjustments a. through n. for the period, including the reversa
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... BURLINGAME, Calif. , Jan. 14, 2014 As pet owners ... no doubt many of them wrote: "Take better care of my ... and even designer clothes and top-brand carrying cases to take the ... Pet parents might also feel compelled to buy some pricey toys ...
(Date:1/14/2014)... The largest international professional organization of scientists ... derivatives thereof has endorsed an educational program that ... challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural Product ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8
... DALLAS , July 21, 2010 According ... Technologies, Global,Forecast and Winning Imperatives (2009-2014)", published by MarketsandMarkets,( ... a $8.3 billion by 2014 at a ... the largest submarket is 2009 at, $1.3 billion , ...
... /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" ... Special Meeting of Shareholders held today, its shareholders, including those ... Han, voted to approve the merger of Datong Investment Inc. ... Agreement and Plan of Merger dated March 26, 2010 ...
... July 20 Fibrocell Science, Inc. (OTC Bulletin Board: FCSC), ... aesthetic, medical and scientific applications, announced today that George J. Korkos ... , , , ... as President of both Plastic Surgery Associates and Rejuva Skin Care & ...
Cached Biology Technology:MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014 2MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014 3MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014 4Dragon Pharma shareholders approve merger and seek termination of listing on the OTCBB and TSX 2Fibrocell Science, Inc. Announces Addition of Dr. George J. Korkos to Board of Directors 2Fibrocell Science, Inc. Announces Addition of Dr. George J. Korkos to Board of Directors 3
(Date:4/17/2014)... IPCC meeting painted a stark warning on the possible ... a greenhouse effect 32 times that of carbon dioxide. ... humic substances act as fully regenerable electron acceptors which ... in wetlands instead of being released to the atmosphere. ... disrupted it may enter into a vicious cycle to ...
(Date:4/17/2014)... Indiana University researchers have detected new early-warning signs of ... discovery could have far-reaching implications for the diagnosis and ... over 25 million Americans. , "We had not expected ... such early stages," said Ann Elsner, professor and associate ... author of the study. "We set out to study ...
(Date:4/17/2014)... at the University of Texas Medical Branch at ... women treated with radiation for cervical cancer should ... , The UTMB researchers, finding a high ... survivors treated with radiation, offer new recommendations that ... cancer screening about eight years after their initial ...
Breaking Biology News(10 mins):Methane climate change risk suggested by proof of redox cycling of humic substances 2New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Radiation therapy for cervical cancer increases risk for colorectal cancer 2
... could help make DNA sequencing affordable enough for clinics ... Andrew Smith, a computational biologist at the USC Dornsife College ... USC graduate student Timothy Daley to help predict the value ... Methods on February 24. Extracting information from ...
... The Children,s Medical Center Research Institute at ... environment within bone marrow that nurtures stem cells, this ... that produce the infection-fighting white blood cells known as ... that cells called early lymphoid progenitors, which are responsible ...
... Bahrami will use his expertise in cooling and heating ... to develop green air conditioning and refrigeration systems (AC-R) ... service vehicle and long-haul truck idling engines. With ... Partnership Canada, the associate professor in Mechatronic Systems Engineering ...
Cached Biology News:Taking the gamble out of DNA sequencing 2Scientists find bone-marrow environment that helps produce infection-fighting T and B cells 2Clean energy research targets idle engines 2Clean energy research targets idle engines 3
Shotgun library construction and high-throughput DNA sequencing of microbial genomes, BACs, adenoviruses, phosmids and cosmids. LIMS tracking utilizing Geospiza's Finch system....
Sequencing and primer design rolled into one. Just give us your clone and a reference sequence, and we'll do the rest. Single-strand or double-strand coverage. Guaranteed results....
...
Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
Biology Products: